欧林生物 (688319.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(欧林生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 160,369,228.45155,478,969.2270,798,700.81143,819,337.10119,099,915.08166,328,341.0666,871,073.79
 营业收入(元) 160,369,228.45155,478,969.2270,798,700.81143,819,337.10119,099,915.08166,328,341.0666,871,073.79
二、营业总成本(元) 135,311,066.36135,375,950.52109,128,006.76162,003,695.04132,410,948.65132,777,326.8863,659,032.05
 营业成本(元) 8,121,868.886,946,621.835,356,618.816,925,350.698,852,816.359,064,776.117,155,208.08
 研发费用(元) 24,111,405.2127,549,589.6947,738,722.7434,448,611.2038,711,268.7822,920,833.1518,648,503.13
 营业税金及附加(元) 627,275.421,197,274.52402,426.721,230,057.70422,983.471,280,921.35388,436.73
 销售费用(元) 82,419,936.8578,897,581.4423,923,785.8297,492,627.3858,026,363.6674,354,035.7127,933,038.83
 管理费用(元) 16,171,023.5617,443,510.7729,430,197.2720,154,545.3225,048,443.9424,231,610.598,878,663.06
 财务费用(元) 3,859,556.443,341,372.272,276,255.401,752,502.751,349,072.45925,149.97655,182.22
  其中:利息费用(元) 4,009,572.393,583,347.962,790,891.372,635,747.701,683,644.081,456,155.871,402,852.97
  其中:利息收入(元) 198,694.18388,351.67514,635.97626,417.45420,509.04726,532.36780,190.58
 资产减值损失(元) -336,932.08-822,023.276,232,979.50-6,992,224.09925,449.475,908,021.54-4,569,100.05
 信用减值损失(元) 6,325,319.66-24,552,762.012,638,065.187,608,161.147,599,013.81-20,873,526.804,079,470.01
三、其他经营收益
 加:投资收益(元) 321,732.34160,235.8218,657.5324,096.13372,904.11-644,728.77
 资产处置收益(元) ----291.26--
 其他收益(元) 895,609.671,678,177.261,129,014.07547,610.642,240,895.0933,677.73431,110.58
四、营业利润(元) 32,263,891.68-3,433,353.50-28,310,589.67-16,996,714.12-2,172,479.8318,469,352.253,798,251.05
 加:营业外收入(元) 2,665.812,329.951,039,197.902,746,051.55803,222.659,000,713.21186.79
 减:营业外支出(元) 100,115.28-7,682.0024,438.059,053.443,068.30--
五、利润总额(元) 32,166,442.21-3,423,341.55-27,295,829.82-14,259,716.01-1,372,325.4827,450,065.463,798,437.84
 减:所得税费用(元) ---351,245.54-979,707.693,353,897.691,449,899.58
六、净利润(元) 30,636,261.00-3,423,341.55-27,295,829.82-14,610,961.55-392,617.7924,096,167.772,348,538.26
(一)按经营持续性分类
  持续经营净利润(元) 30,636,261.00-3,423,341.55-27,295,829.82-14,610,961.55-392,617.7924,096,167.772,348,538.26
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 31,972,906.60-1,950,069.85-25,996,930.16-12,728,198.081,737,688.7924,692,437.913,853,633.15
  少数股东损益(元) -1,336,645.60-1,473,271.70-1,298,899.66-1,882,763.47-2,130,306.58-596,270.14-1,505,094.89
 扣除非经常性损益后的净利润(元) 31,583,137.21-4,078,297.15-27,836,938.18-15,538,520.94-1,168,246.2617,155,800.032,939,010.93
七、每股收益
 一、基本每股收益(元) 0.08--0.06-0.03-0.060.01
 二、稀释每股收益(元) 0.08--0.06-0.03-0.060.01
九、综合收益总额(元) 30,636,261.00-3,423,341.55-27,295,829.82-14,610,961.55-392,617.7924,096,167.772,348,538.26
 归属于母公司所有者的综合收益总额(元) 31,972,906.60-1,950,069.85-25,996,930.16-12,728,198.081,737,688.7924,692,437.913,853,633.15
 归属于少数股东的综合收益总额(元) -1,336,645.60-1,473,271.70-1,298,899.66-1,882,763.47-2,130,306.58-596,270.14-1,505,094.89
公告日期 2024-10-302024-08-222024-04-262024-04-262023-10-272023-08-182023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院